top of page

📈 Top-5 Growth Stocks — November 15, 2026

Rod Fontecilla
2 days ago
10 min read

Weekly growth screen · prices as of the Friday, November 13, 2026 close · published Sunday, November 15, 2026


⚠️ Read this first

This is not a week to be a hero with position size. Three things collided in the last five sessions. First, the rates picture turned decisively hawkish: October CPI printed 0.4% month over month (core 0.3% for a third straight month), October payrolls came in at 165,000, roughly two and a half times consensus, and the 10-year Treasury finished the week at 5.15%, up 29 basis points, with the 2-year at 4.88%. CME FedWatch now treats a quarter-point hike at the December 8–9 FOMC as essentially certain (91–100% depending on the snapshot), with a minority pricing 50 basis points. Growth multiples do not expand into that. Second, Jensen Huang resigned as NVIDIA's CEO on November 12, with CFO Colette Kress named interim CEO and a congressional inquiry pending; the stock closed Friday at $162.85, roughly 33% below its October 6 high, and reports Q3 FY27 results after the close on Tuesday, November 17, with options implying an 8–9% move. That print will set the tone for every name on this list. Third, the week itself is dense: Fed Chair Warsh speaks Monday, retail sales land Tuesday morning, the October FOMC minutes come Wednesday, the Anthropic IPO is slated to begin trading Thursday, and Governors Waller and Cook speak Friday.


Practical translation: treat these as half-size starter positions, stagger entries across the week rather than buying Monday's open, and avoid adding to semiconductor exposure ahead of the NVIDIA print. The index backdrop is firmer than the headlines suggest (the S&P 500 gained 2.5% last week to 7,562 and sits only about 3% below its October 6 close), which is exactly why discipline matters: the market has already bounced once, and a hawkish Fed plus a soft NVIDIA guide could take it back.


How the list was built

The starting universe is Yahoo Finance's predefined growth-technology screen, which requires quarterly revenue growth and one-year EPS growth both above 25%; it returned 63 names this week. I removed preferreds and warrants (SMCIP, CORZW, CORZZ, ORCL-PD, GRABW), anything under $5 billion in market capitalization, and thinly traded tickers, which left 18 candidates. For each I pulled the consensus 12-month price target, the Strong Buy/Buy/Hold/Sell split, and current- and next-fiscal-year revenue and EPS forecasts from StockAnalysis (S&P Global and TipRanks data), cross-checked against Yahoo's one-year target estimate, and then read the latest earnings release, guidance, and news flow for the top eight. The ranking weighs four things: durability of growth into the next fiscal year, upside to the average target and the shape of the target range (a low target above the current price is a strong signal), a confirmed near-term catalyst, and recent price behavior.


One housekeeping note. Several data pages for WDC, CIEN, SIMO, TER, APH, SMTC, FN and VICR were served with quotes dated October 23 through November 5 rather than Friday's close, and I could not obtain a verified November 13 price for them from an alternate source. Rather than rank names on prices I cannot confirm, those eight appear in the full table flagged with their quote date and are excluded from this week's five. Also, charts are omitted from this post; the tables below carry the same figures.


The ranking

1. Broadcom (AVGO)

Broadcom closed at $347.01, with an average analyst target of $533.42 for +53.7% implied upside and, more tellingly, a low target of $400 that sits 15.3% above the current price; all 51 analysts tracked rate it Strong Buy or Buy except two Holds (49 of 51). Consensus has revenue growing +65.9% in FY26 (October year-end) and +64.4% in FY27, with EPS up +71.1% and +66.9%; that is the most durable two-year growth profile in the group at this scale. The catalyst is dated: Q4 and full-year FY26 results on December 9. The stock was one of the week's beneficiaries of the rotation out of NVIDIA, rising more than 5% on Thursday, and is up 5.6% since October 16 while most of the group is down. Risk: custom-silicon (XPU) revenue is concentrated in a handful of hyperscalers, and the stock is still some 20% below its 200-day average, so a soft AI-capex comment from any of them hits it directly.


2. Taiwan Semiconductor (TSM)

TSMC's ADR closed at $398.73 against an average target of $586.69 (+47.1% upside) and a low target of $440 that is 10.4% above the price; 20 of 21 analysts are at Buy or better. The fundamental news this week was the cleanest in the sector: October revenue of NT$586.9 billion was a record, up 14.7% month over month and 59.7% year over year, and it already exceeds the monthly pace implied by the Q4 guide of US$52.3–54.3 billion. Consensus has revenue up +46.6% this year and +37.8% next, with EPS growth of +67.0% and +35.2%, and the stock trades near 16x forward earnings versus a five-year average around 18x. Next catalysts are November sales around December 10 and the 2027 outlook in mid-January. The stock is down only 3.4% since mid-October, the most stable chart among the finalists. Risk: it is the ultimate NVIDIA supplier, so a weak NVIDIA data-center guide on Tuesday will be read through to it, and Taiwan geopolitical risk never leaves the discount.


3. Lam Research (LRCX)

Lam closed at $225.92, with an average target of $362.10 (+60.3% upside), a low target of $255 (12.9% above the price) and 30 of 34 analysts at Buy or better. The company's board authorized a $25 billion share repurchase on November 5, on top of what remained of the prior program, and declared a $0.33 quarterly dividend (record December 2, payable January 6). Consensus revenue growth is +52.4% for FY27 (June year-end) and +20.4% for FY28, with EPS up +65.8% then +26.8%. Lam's growth is slower next year than Broadcom's or Astera's, but the combination of a low target above the price, a Strong Buy consensus, and a buyback equal to roughly 9% of the market cap is the kind of downside support that matters in a hawkish-Fed week. The stock is down 14.4% since October 16, so the entry is better than it was a month ago. Risk: wafer-fab-equipment orders are the most cyclical part of the AI chain, and China export controls remain a live variable.


4. Astera Labs (ALAB)

Astera closed at $221.83, with an average target of $344.15 (+55.1% upside, high target $500) and 18 of 25 analysts at Buy or better. It is the fastest grower on the list by a wide margin: consensus revenue up +137.8% in FY26 and +65.4% in FY27, with EPS up +138.1% and +62.4%. The November 3 report backed that up, with Q3 revenue of $584.9 million (up 154% year over year and 49% sequentially, versus roughly $550 million expected), non-GAAP EPS of $1.32, a 72.4% gross margin, and Q4 guidance of $730–750 million against a $655.7 million consensus as the Scorpio X-series switch became the largest product line. The stock has bounced from $190.71 on November 6 to $221.83 but is still 22.4% below its October 16 level. Risk: the low target of $190 sits 14.3% below the current price and the stock trades at a triple-digit trailing P/E, so this is the highest-beta pick and should be the smallest position of the five.


5. Advanced Micro Devices (AMD)

AMD closed at $534.06, having gained roughly 19% since November 6, and now sits just 23.2% below its $657.74 average target, with a low target of $525 fractionally below the price; 47 of 54 analysts rate it Buy or better. What earns it the fifth slot is the growth trajectory into next year: consensus has revenue up +50.8% in FY26 and accelerating to +83.6% in FY27, with EPS up +93.9% then +118.8%, the only name in the group where growth speeds up rather than slows. The November 4 report delivered Q3 revenue of $13.38 billion (versus $13.06 billion expected), a record $8.55 billion in data-center revenue that nearly doubled year over year, and a Q4 guide of about $17 billion against a $16.23 billion consensus. Like Broadcom, AMD was a Thursday beneficiary of the rotation away from NVIDIA. Risk: with the stock back near the average target after a sharp rally, the near-term reward-to-risk is the thinnest of the five; this is a hold-and-add-on-weakness position, not a chase.


Snapshot: the five picks

Ticker

Price

Avg target (upside)

Low / High

Buy / total

Rev growth FY / FY+1

EPS growth FY / FY+1

Since Oct 16

AVGO

$347.01

$533.42 (+53.7%)

$400.00 / $660.00

49/51

+65.9% / +64.4%

+71.1% / +66.9%

+5.6%

TSM

$398.73

$586.69 (+47.1%)

$440.00 / $1,000.00

20/21

+46.6% / +37.8%

+67.0% / +35.2%

-3.4%

LRCX

$225.92

$362.10 (+60.3%)

$255.00 / $500.00

30/34

+52.4% / +20.4%

+65.8% / +26.8%

-14.4%

ALAB

$221.83

$344.15 (+55.1%)

$190.00 / $500.00

18/25

+137.8% / +65.4%

+138.1% / +62.4%

-22.4%

AMD

$534.06

$657.74 (+23.2%)

$525.00 / $1,250.00

47/54

+50.8% / +83.6%

+93.9% / +118.8%

+1.0%


Full analysis table

Prices are the November 13, 2026 close unless a date is shown in parentheses. Upside is measured against the price shown. Growth figures are consensus for the current fiscal year and the next one; fiscal-year conventions vary (AVGO, CIEN, KEYS end in October; LRCX, WDC, FN in June; MU in August; NVDA and SMTC in January).

Ticker

Price

Avg target (upside)

Low / High

Buy / total

Rev growth FY / FY+1

EPS growth FY / FY+1

Since Oct 16

AVGO

$347.01

$533.42 (+53.7%)

$400.00 / $660.00

49/51

+65.9% / +64.4%

+71.1% / +66.9%

+5.6%

TSM

$398.73

$586.69 (+47.1%)

$440.00 / $1,000.00

20/21

+46.6% / +37.8%

+67.0% / +35.2%

-3.4%

LRCX

$225.92

$362.10 (+60.3%)

$255.00 / $500.00

30/34

+52.4% / +20.4%

+65.8% / +26.8%

-14.4%

ALAB

$221.83

$344.15 (+55.1%)

$190.00 / $500.00

18/25

+137.8% / +65.4%

+138.1% / +62.4%

-22.4%

AMD

$534.06

$657.74 (+23.2%)

$525.00 / $1,250.00

47/54

+50.8% / +83.6%

+93.9% / +118.8%

+1.0%

MU

$778.31

$1,562.00 (+100.7%)

$361.00 / $3,000.00

45/49

+107.1% / +16.0%

+133.7% / +17.7%

-11.4%

NVDA

$162.85

$279.63 (+71.7%)

$170.00 / $515.00

47/61

+90.7% / +67.1%

+95.5% / +69.8%

-23.9%

CRDO

$131.51

$284.05 (+116.0%)

n/a

n/a

n/a

n/a

-22.5%

PLTR

$167.99

$222.25 (+32.3%)

$80.00 / $273.00

22/33

+91.1% / +52.7%

+127.0% / +47.6%

-9.7%

KEYS

$297.68

$419.67 (+41.0%)

$350.00 / $487.00

10/12

+32.4% / +15.4%

+60.3% / +21.4%

-10.1%

WDC

$343.67 (Oct 23)

$610.04 (+77.5%)

$405.00 / $900.00

21/26

+64.9% / +36.9%

+143.2% / +59.1%

+3.5%

CIEN

$335.93 (Oct 26)

$512.99 (+52.7%)

$347.00 / $660.00

16/21

+34.7% / +30.8%

+171.4% / +65.1%

+1.0%

SIMO

$189.18 (Oct 26)

$369.70 (+95.4%)

$325.00 / $450.00

11/12

+111.7% / +29.6%

+213.7% / +42.5%

-10.5%

TER

$309.00 (Oct 26)

$424.67 (+37.4%)

$340.00 / $550.00

12/17

+64.0% / +23.8%

+138.5% / +26.0%

-4.9%

APH

$79.30 (Oct 30)

$102.97 (+29.8%)

$85.00 / $116.00

17/19

+54.4% / +19.6%

+61.0% / +24.0%

-0.1%

SMTC

$136.73 (Oct 26)

$217.07 (+58.8%)

$186.00 / $300.00

15/16

+43.2% / +35.9%

+113.5% / +82.8%

+0.0%

FN

$325.24 (Oct 26)

$687.78 (+111.5%)

$431.00 / $800.00

7/9

+31.7% / +20.0%

+29.4% / +20.3%

-10.5%

VICR

$135.10 (Nov 5)

$390.00 (+188.7%)

$350.00 / $450.00

4/4

+57.5% / +46.9%

+40.6% / +44.1%

-29.5%


Why the others didn't make it

NVIDIA screens as a buy on numbers alone: $162.85 against a $279.63 average target (+71.7%), a low target of $170 that is above the price, and 47 of 61 analysts at Buy or better, with revenue expected to grow +90.7% this fiscal year. But a founder-CEO resigning five days before earnings, a congressional probe, and the possibility of tighter export restrictions is not a setup for a weekly screen to front-run; the stock is down 23.9% since October 16 and the Tuesday print is a coin flip with an 8–9% implied move. It is the first alternate, and a clean report with the dividend-of-doubt removed could put it back at the top next week. Micron offers the largest headline upside (+100.7% to a $1,562.00 average) and 45 of 49 Buys, but consensus revenue growth collapses from +107.1% in FY27 to +16.0% in FY28, the target range runs from $361 to $3,000, the stock fell 17.5% in a single session on November 5, and Bloomberg reported it has suspended a $4.5 billion Taiwan plant; the December 16 report is the catalyst, and it is the second alternate. Credo is down 22.5% since mid-October with a stale forecast page, so I could not verify its consensus. Palantir and Keysight have narrower upside (32% and 41%) and, in Palantir's case, a low target of $80 and a trailing P/E above 150. Western Digital, Ciena, Silicon Motion, Teradyne, Amphenol, Semtech, Fabrinet and Vicor could not be priced as of Friday's close and are shown for reference only; on their late-October quotes WDC (77% upside, low target 18% above price) and SIMO (95% upside, low target 72% above price) would otherwise have been serious contenders, and both are worth re-checking next week.


Sources

  • Yahoo Finance growth-technology screener (revenue and EPS growth above 25%), 63 results, November 14–15, 2026.

  • StockAnalysis.com forecast and price-history pages for each candidate (S&P Global Market Intelligence / TipRanks data); Yahoo Finance quote pages for 1-year target estimates.

  • NVIDIA press release, "NVIDIA Announces CEO Transition," November 12, 2026; Schwab Market Update, November 13, 2026.

  • TSMC October 2026 revenue report (pr.tsmc.com), November 10, 2026; TIKR analysis, November 11, 2026.

  • AMD Q3 2026 results coverage (Finviz/PR), November 4, 2026; Astera Labs Q3 2026 results coverage (Tiger Brokers), November 4, 2026.

  • Lam Research $25 billion repurchase authorization (PR Newswire), November 5, 2026; Broadcom Q4 FY26 earnings-date notice (December 9, 2026).

  • Western Digital/Kioxia analysis (TIKR), November 4, 2026; Micron analysis (Trefis), November 6, 2026.

  • Investing.com, "Fed turns hawkish as CPI beats," November 13, 2026; 24/7 Wall St via Yahoo Finance on December hike odds, November 7, 2026; Investomine weekly market report for the week to November 13, 2026; CMC Markets and Yahoo Finance week-ahead previews.


⚖️ Disclaimer

This post is published for informational and educational purposes only. Nothing here is individualized investment advice, a recommendation tailored to any person's circumstances, an offer, or a solicitation to buy or sell any security or financial instrument. This post is not an investment advisory service, and no advisory or fiduciary relationship is created between me and any reader. I am not a registered investment adviser, broker-dealer, or financial planner. The indicators, thresholds, status ratings, and scenario probabilities are my own subjective framework and judgment, not forecasts or guarantees; they can be and often will be wrong. Data are drawn from third-party public sources believed to be reliable but not independently verified, may be preliminary, revised, delayed, or contain errors, and are current only as of the date shown. Portions of this post are produced with the assistance of AI tools and may contain inaccuracies. Past performance and historical relationships do not guarantee future results. Investing involves risk, including the possible loss of principal. You are solely responsible for your own investment decisions and should consult a licensed financial, tax, or legal professional before acting on anything you read here. I may hold positions in securities or asset classes discussed and may trade them without notice. To the fullest extent permitted by law, I disclaim all liability for any loss or damage arising from reliance on this content. Links to third-party sites are provided for convenience only and do not constitute an endorsement.


Auto-generated by the Weekly Growth Stock Screen · November 15, 2026 · Next run: November 22, 2026

 
 

Recent Posts

See All
GovCon Tech Weekly — November 16, 2026

Quietly Issued: GSA's Schedule refresh carrying the new AI clause issued on Thursday, November 12 — three days after this brief reported it still unissued — and started a 90-day mass-modification cloc

 
 
GovCon Tech Weekly — November 9, 2026

Paused, Not Pardoned: a defense contractor paid $13 million to settle allegations it failed NIST SP 800-171 while CMMC Phase 2 remains suspended with no restart date — the controls are unenforced as a

 
 
bottom of page